var singsData = [{"date":new Date(2012,10,20),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Brean Capital initiates coverage on COV to Buy. Target Price is $66.","showOnAxis":false},{"date":new Date(2012,10,20),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Stifel Nicolaus initiates coverage on COV to Hold.","showOnAxis":false},{"date":new Date(2012,10,9),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"COV reports 2012 Q4's earning $1.02 per share and revenue $3000MM. This beats analyst's estimated EPS $1, beats estimated revenue $2980MM.","showOnAxis":false},{"date":new Date(2012,11,31),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Goldman Sachs maintains COV to Neutral. Target Price is $63; previously $62.","showOnAxis":false},{"date":new Date(2012,2,14),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains COV to Buy. Target Price is $61; previously $57.","showOnAxis":false},{"date":new Date(2012,2,19),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Morgan Keegan maintains COV to Outperform. Target Price is $63; previously $60.","showOnAxis":false},{"date":new Date(2012,3,30),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Bank oferica maintains COV to Buy. Target Price is $64; previously $61.","showOnAxis":false},{"date":new Date(2012,3,30),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains COV to Buy. Target Price is $64; previously $60.","showOnAxis":false},{"date":new Date(2012,3,30),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Morgan Stanley maintains COV to Overweight. Target Price is $61; previously $56.","showOnAxis":false},{"date":new Date(2012,3,30),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"PiperJaffray maintains COV to Overweight. Target Price is $64; previously $60.","showOnAxis":false},{"date":new Date(2012,4,1),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains COV to Buy. Target Price is $62; previously $59.","showOnAxis":false},{"date":new Date(2012,4,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains COV to Overweight. Target Price is $64; previously $59.","showOnAxis":false},{"date":new Date(2012,6,26),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, COV reports 2012 Q3's earning $1.07 per share and revenue $3010MM. This beats analyst's estimated EPS $1.06, meets estimated revenue $3010MM.","showOnAxis":false},{"date":new Date(2012,8,14),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains COV to Buy. Target Price is $68; previously $64.","showOnAxis":false},{"date":new Date(2012,8,14),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains COV to Buy. Target Price is $66; previously $61.","showOnAxis":false},{"date":new Date(2013,0,25),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, COV reports 2013 Q1's earning $1.1 per share and revenue $3060MM. This beats analyst's estimated EPS $1.06, beats estimated revenue $3000MM.","showOnAxis":false},{"date":new Date(2013,0,25),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains COV to Overweight. Target Price is $66; previously $64.","showOnAxis":false},{"date":new Date(2013,0,25),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"PiperJaffray maintains COV to Overweight. Target Price is $71; previously $64.","showOnAxis":false},{"date":new Date(2013,0,28),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Bank of America maintains COV to Buy. Target Price is $68; previously $64.","showOnAxis":false},{"date":new Date(2013,0,28),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains COV to Buy. Target Price is $71; previously $64.","showOnAxis":false},{"date":new Date(2013,0,28),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Goldman Sachs maintains COV to Neutral. Target Price is $66; previously $63.","showOnAxis":false},{"date":new Date(2013,0,4),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains COV to Buy. Target Price is $70; previously $64.","showOnAxis":false},{"date":new Date(2013,11,5),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Benchmark initiates coverage on COV to Buy. Target Price is $82.","showOnAxis":false},{"date":new Date(2013,2,27),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains COV to Buy. Target Price is $75; previously $66.","showOnAxis":false},{"date":new Date(2013,2,6),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Atlantic Equities initiates coverage on COV to Overweight. Target Price is $75.","showOnAxis":false},{"date":new Date(2013,3,12),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains COV to Buy. Target Price is $74; previously $70.","showOnAxis":false},{"date":new Date(2013,3,26),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, COV reports 2013 Q2's earning $1.12 per share and revenue $3100MM. This beats analyst's estimated EPS $1.09, misses estimated revenue $3120MM.","showOnAxis":false},{"date":new Date(2013,5,28),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"BMO Capital maintains COV to Outperform. Target Price is $64; previously $72.","showOnAxis":false},{"date":new Date(2013,7,1),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, COV reports 2013 Q3's earning $0.91 per share and revenue $2580MM. This beats analyst's estimated EPS $0.89, meets estimated revenue $2580MM.","showOnAxis":false},{"date":new Date(2013,7,2),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains COV to Buy. Target Price is $70; previously $68.","showOnAxis":false},{"date":new Date(2013,8,16),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains COV to Buy. Target Price is $68; previously $72.","showOnAxis":false},{"date":new Date(2014,1,26),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"CRT Capital initiates coverage on COV to Buy. Target Price is $82.","showOnAxis":false},{"date":new Date(2014,10,6),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains COV to Buy. Target Price is $107; previously $96.","showOnAxis":false},{"date":new Date(2014,2,11),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"BTIG Research initiates coverage on COV to Buy. Target Price is $83.","showOnAxis":false},{"date":new Date(2014,2,27),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains COV to Overweight. Target Price is $79; previously $74.","showOnAxis":false},{"date":new Date(2014,3,28),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains COV to Buy. Target Price is $81; previously $83.","showOnAxis":false},{"date":new Date(2014,5,16),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Benchmark downgrades COV to Hold from Buy. Target Price is $93; previously $82.","showOnAxis":false},{"date":new Date(2014,5,16),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"CRT Capital downgrades COV to Fair Value from Buy. Target Price is $93.22; previously $82.","showOnAxis":false},{"date":new Date(2014,5,16),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"William Blair downgrades COV to Market Perform from Outperform.","showOnAxis":false},{"date":new Date(2014,5,18),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"BMO Capital downgrades COV to Market Perform from Outperform. Target Price is $93.22; previously $78.","showOnAxis":false},{"date":new Date(2014,5,18),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Barclays downgrades COV to Equal-weight from Overweight. Target Price is $93; previously $82.","showOnAxis":false},{"date":new Date(2014,5,23),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Leerink Swann downgrades COV to Market Perform from Outperform.","showOnAxis":false},{"date":new Date(2014,5,27),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"BTIG Research downgrades COV to Neutral from Buy.","showOnAxis":false},{"date":new Date(2014,5,27),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Raymond James downgrades COV to Outperform from Strong Buy. Target Price is $97.","showOnAxis":false},{"date":new Date(2014,6,14),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"PiperJaffray downgrades COV to Neutral from Overweight.","showOnAxis":false},{"date":new Date(2014,6,17),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Needham downgrades COV to Hold from Buy; previously $80.","showOnAxis":false},{"date":new Date(2014,6,28),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains COV to Buy. Target Price is $101; previously $81.","showOnAxis":false},{"date":new Date(2014,6,28),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains COV to Buy. Target Price is $96; previously $80.","showOnAxis":false},{"date":new Date(2014,9,3),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Morgan Stanley downgrades COV to Equal-Weight from Overweight.","showOnAxis":false}];